Thrombolytic Therapy for Pulmonary Embolism

This publication has 24 references indexed in Scilit:

• Hemorrhagic Complications of Thrombolytic Therapy in the Treatment of Myocardial Infarction and Venous Thromboembolism
  Chest, 1995
• Reduced Dose Bolus Alteplase vs Conventional Alteplase Infusion for Pulmonary Embolism Thrombolysis
  Chest, 1994
• Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion
  The Lancet, 1993
• Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial
  Journal of the American College of Cardiology, 1992
• RANDOMISED CONTROLLED TRIAL OF RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR VERSUS UROKINASE IN THE TREATMENT OF ACUTE PULMONARY EMBOLISM
  The Lancet, 1988
• Thrombolytic therapy of acute pulmonary embolism: Current status and future potential
  Journal of the American College of Cardiology, 1987
• Perspectives on Treatment of Acute Pulmonary Embolism with Tissue Plasminogen Activator
  Seminars in Thrombosis and Hemostasis, 1987
• The UKEP study: Multicentre clinical trial on two local regimens of urokinase in massive pulmonary embolism
  European Heart Journal, 1987
• ACUTE PULMONARY EMBOLISM TREATED WITH TISSUE PLASMINOGEN ACTIVATOR
  The Lancet, 1986
• Urokinase-Streptokinase Embolism Trial
  JAMA, 1974